BOTALYS Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

BOTALYS General Information

Description

Producer of potent botanicals intended to make the sourcing of rare medicinal plants easy and sustainable. The company uses indoor vertical farming to reproduce and optimize wild-like growth conditions by meticulously setting up each environmental parameter, such as temperature, substrate, and access to nutrients, among others, in an indoor sterile environment, enabling businesses to provide customers with traceable, pure, and bioactive ingredients.

Contact Information

Website
www.botalys.com
Formerly Known As
Green2Chem
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenue des Artisans 8 Box 6
  • 7822 Ghislenghien
  • Belgium
+32 068
Primary Industry
Specialty Chemicals
Corporate Office
  • Avenue des Artisans 8 Box 6
  • 7822 Ghislenghien
  • Belgium
+32 068

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BOTALYS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Later Stage VC (Series B) 29-Sep-2022 Completed Generating Revenue
6. Later Stage VC 14-Jan-2020 Completed Generating Revenue
5. Grant 26-Mar-2019 Completed Generating Revenue
4. Later Stage VC 09-Jan-2019 Completed Generating Revenue
3. Grant 31-May-2017 Completed Generating Revenue
2. Later Stage VC 22-Sep-2016 $560K $560K Completed Generating Revenue
1. Accelerator/Incubator 01-Feb-2016 Completed Generating Revenue
To view BOTALYS’s complete valuation and funding history, request access »

BOTALYS Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class H
Class H
Class G
Class F
Class D
Class B 36,900 $8.93 $8.93 1x $8.93 1.91%
Ordinary 142,500 $0.72 $0.72 1x $0.72 7.37%
To view BOTALYS’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BOTALYS Patents

BOTALYS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022553120-A Carrot composition and its use as a medicament Pending 03-Sep-2019
AU-2020342706-A1 Ginseng composition and use thereof as a medicament Inactive 03-Sep-2019
EP-4025231-A1 Ginseng composition and use thereof as a medicament Active 03-Sep-2019
EP-4025231-B1 Ginseng composition and use thereof as a medicament Active 03-Sep-2019
EP-4025231-C0 Ginseng composition and use thereof as a medicament Active 03-Sep-2019 A61K36/258
To view BOTALYS’s complete patent history, request access »

BOTALYS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BOTALYS Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aliad Corporation Minority
The Yield Lab Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
European Union Government
Horizon 2020 Government
You’re viewing 5 of 6 investors. Get the full list »

BOTALYS Acquisitions (1)

BOTALYS’s most recent deal was a Merger/Acquisition with ROOTec bioactives. The deal was made on 01-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ROOTec bioactives 01-Mar-2016 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view BOTALYS’s complete acquisitions history, request access »

BOTALYS FAQs

  • When was BOTALYS founded?

    BOTALYS was founded in 2011.

  • Where is BOTALYS headquartered?

    BOTALYS is headquartered in Ghislenghien, Belgium.

  • What is the size of BOTALYS?

    BOTALYS has 28 total employees.

  • What industry is BOTALYS in?

    BOTALYS’s primary industry is Specialty Chemicals.

  • Is BOTALYS a private or public company?

    BOTALYS is a Private company.

  • What is BOTALYS’s current revenue?

    The current revenue for BOTALYS is .

  • How much funding has BOTALYS raised over time?

    BOTALYS has raised $18M.

  • Who are BOTALYS’s investors?

    Aliad, The Yield Lab, European Innovation Council, European Union, and Horizon 2020 are 5 of 6 investors who have invested in BOTALYS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process